Kortylewski M - Search Results

1

Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.

Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B, Wang L, Kowolik C, Deng J, Figlin R, Yu H. Herrmann A, et al. Among authors: kortylewski m. Cancer Res. 2010 Oct 1;70(19):7455-64. doi: 10.1158/0008-5472.CAN-10-0736. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841481 Free PMC article.

2

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3.

Hall J, Zhang Z, Wang D, Bhattacharya S, Alcantara M, Liang Y, Swiderski P, Forman S, Kwak L, Vaidehi N, Kortylewski M. Hall J, et al. Among authors: kortylewski m. bioRxiv [Preprint]. 2023 Aug 3:2023.08.01.551552. doi: 10.1101/2023.08.01.551552. bioRxiv. 2023. Update in: Mol Ther Nucleic Acids. 2024 Feb 05;35(1):102137. doi: 10.1016/j.omtn.2024.102137 PMID: 37577590 Free PMC article. Updated. Preprint.

3

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.

Burdelya L, Kujawski M, Niu G, Zhong B, Wang T, Zhang S, Kortylewski M, Shain K, Kay H, Djeu J, Dalton W, Pardoll D, Wei S, Yu H. Burdelya L, et al. Among authors: kortylewski m. J Immunol. 2005 Apr 1;174(7):3925-31. doi: 10.4049/jimmunol.174.7.3925. J Immunol. 2005. PMID: 15778348 Free PMC article.

4

Targeting STAT3 affects melanoma on multiple fronts.

Kortylewski M, Jove R, Yu H. Kortylewski M, et al. Cancer Metastasis Rev. 2005 Jun;24(2):315-27. doi: 10.1007/s10555-005-1580-1. Cancer Metastasis Rev. 2005. PMID: 15986140 Review.

5

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.

Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H. Xu Q, et al. Among authors: kortylewski m. Oncogene. 2005 Aug 25;24(36):5552-60. doi: 10.1038/sj.onc.1208719. Oncogene. 2005. PMID: 16007214

6

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mulé J, Kerr WG, Jove R, Pardoll D, Yu H. Kortylewski M, et al. Nat Med. 2005 Dec;11(12):1314-21. doi: 10.1038/nm1325. Epub 2005 Nov 20. Nat Med. 2005. PMID: 16288283

7

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Yu H, Kortylewski M, Pardoll D. Yu H, et al. Among authors: kortylewski m. Nat Rev Immunol. 2007 Jan;7(1):41-51. doi: 10.1038/nri1995. Nat Rev Immunol. 2007. PMID: 17186030 Review.

8

Stat3 as a potential target for cancer immunotherapy.

Kortylewski M, Yu H. Kortylewski M, et al. J Immunother. 2007 Feb-Mar;30(2):131-9. doi: 10.1097/01.cji.0000211327.76266.65. J Immunother. 2007. PMID: 17471161 Review.

9

Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG. Harris TJ, et al. Among authors: kortylewski m. J Immunol. 2007 Oct 1;179(7):4313-7. doi: 10.4049/jimmunol.179.7.4313. J Immunol. 2007. PMID: 17878325

10

Role of Stat3 in suppressing anti-tumor immunity.

Kortylewski M, Yu H. Kortylewski M, et al. Curr Opin Immunol. 2008 Apr;20(2):228-33. doi: 10.1016/j.coi.2008.03.010. Epub 2008 May 12. Curr Opin Immunol. 2008. PMID: 18479894 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters